首站-论文投稿智能助手
典型文献
Molecular targeted therapies for pediatric atypical teratoid/rhabdoid tumors
文献摘要:
Atypical teratoid/rhabdoid tumors (AT/RTs) are lethal central nervous system tumors, which are primarily diagnosed in infants. Current treatments for AT/RTs include surgery, radiotherapy, and chemotherapy; these treatments have poor prognoses and challenging side effects. The pivotal genetic event in AT/RT pathogenesis comprises the inactivation of SMARCB1 or SMARCA4. Recent epigenetic studies have demonstrated mutual and subtype-specific epigenetic derangements that drive tumorigenesis; the exploitation of these potential targets might improve the dismal treatment outcomes of AT/RTs. This review aims to summarize the literature concerning targeted molecular therapies for pediatric AT/RTs.
文献关键词:
Atypical teratoid/rhabdoid tumors;SMARCB1;SMARCA4;SWI/SNF complex;Targeted molecular therapy
作者姓名:
Zhang Chang;Li Hao
作者机构:
Department of Neurosurgery, Children’s Hospital of Fudan University, Shanghai, China
引用格式:
[1]Zhang Chang;Li Hao-.Molecular targeted therapies for pediatric atypical teratoid/rhabdoid tumors)[J].儿科学研究(英文),2022(02):111-122
A类:
RTs,derangements
B类:
Molecular,targeted,therapies,pediatric,atypical,teratoid,rhabdoid,tumors,Atypical,AT,are,lethal,central,nervous,system,which,primarily,diagnosed,infants,Current,treatments,include,surgery,radiotherapy,chemotherapy,these,have,poor,prognoses,challenging,side,effects,pivotal,event,pathogenesis,comprises,inactivation,SMARCB1,SMARCA4,Recent,epigenetic,studies,demonstrated,mutual,subtype,specific,that,drive,tumorigenesis,exploitation,potential,targets,might,improve,dismal,outcomes,This,review,aims,summarize,literature,concerning,molecular,SWI,SNF,complex,Targeted
AB值:
0.598815
相似文献
Efficacy of rigosertib, a small molecular RAS signaling disrupter for the treatment of KRAS-mutant colorectal cancer
Xinyi Zhou;Qian Xiao;Dongliang Fu;Haochen Zhang;Yang Tang;Jinjie He;Yeting Hu;Xiangxing Kong;Fei Teng;Xiangrui Liu;Ying Yuan;Kefeng Ding-Department of Colorectal Surgery and Oncology,Key Laboratory of Cancer Prevention and Intervention,Ministry of Education,the Second Affiliated Hospital of Zhejiang University School of Medicine,Hangzhou 310009,China;Department of Medical Oncology,Key Laboratory of Cancer Prevention and Intervention,Ministry of Education,the Second Affiliated Hospital of Zhejiang University School of Medicine,Hangzhou 310009,China;Hangzhou Oncocare Co Ltd,Hangzhou 310009,China;Department of Pharmacology,Zhejiang University School of Medicine,Hangzhou 310058,China;Cancer Center,Zhejiang University,Hangzhou 310009,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。